**Core Concept:** Vigabatrin is an antiepileptic drug that primarily inhibits the enzyme GABA transaminase, which leads to an increase in gamma-aminobutyric acid (GABA) levels in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system (CNS) and plays a crucial role in controlling neuronal excitability.

**Why the Correct Answer is Right:** Vigabatrin is a selective inhibitor of GABA transaminase, the enzyme responsible for the degradation of GABA. By inhibiting this enzyme, vigabatrin increases the levels of GABA in the brain, leading to a decrease in neuronal excitability and, consequently, a reduction in seizure activity.

**Why Each Wrong Option is Incorrect:**

A. Vigabatrin acts as a GABA agonist: This option is incorrect because vigabatrin does not directly bind to GABA receptors but rather increases GABA levels by inhibiting its degradation.

B. Vigabatrin alters glutamate levels: Although glutamate is a neurotransmitter involved in excitatory signaling in the CNS, vigabatrin does not specifically target glutamate levels but rather increases GABA levels as described above.

C. Vigabatrin increases dopamine levels: Similar to glutamate, dopamine is a neurotransmitter involved in various physiological processes, but the drug's mechanism of action primarily focuses on GABA, not dopamine.

D. Vigabatrin enhances glycine levels: Glycine is another neurotransmitter in the CNS, but the drug's effect is primarily on GABA, not glycine.

**Clinical Pearl:** Vigabatrin's primary mechanism of action is to increase GABA levels in the brain, which is crucial for its antiepileptic effect.

**Correct Answer:** D. Vigabatrin enhances GABA levels.

**Why the Correct Answer is Right:** Vigabatrin increases GABA levels in the brain by inhibiting its degradation, which leads to a reduction in seizure activity. This is because GABA is the primary inhibitory neurotransmitter in the CNS, and enhancing its levels helps counteract excessive neuronal excitability and seizures.

**Why Each Wrong Option is Incorrect:**

A. Vigabatrin directly activates GABA receptors: The drug does not directly bind to GABA receptors but increases GABA levels indirectly by inhibiting its degradation.

B. Vigabatrin modulates glutamate levels: Although glutamate is involved in excitatory signaling, the drug's primary mechanism focuses on GABA, not glutamate.

C. Vigabatrin alters dopamine levels: Dopamine is involved in various physiological processes, but the drug's effect is primarily on GABA, not dopamine.

D. Vigabatrin enhances glycine levels: Glycine is another neurotransmitter in the CNS, but the drug's effect is primarily on GABA, not glycine.